# SYMPROIC
> **NDA208854** · New Drug Application · Sponsor: BDSI · Approved 2017-03-23
## Drug
- **FDA Application Number:** NDA208854
- **Application type:** New Drug Application
- **Brand name:** SYMPROIC
- **Generic name:** NALDEMEDINE
- **Active ingredients:** NALDEMEDINE TOSYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** BDSI
- **Manufacturer:** BioDelivery Sciences International Inc
- **First approval:** 2017-03-23
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=208854)
---
*MORVS · CC0 1.0*